Quantitative Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-76,682
| Closed | -$2.31M | – | 517 |
|
|
2026
Q1 | $2.31M | Buy |
+76,682
| New | +$2.47M | 0.24% | 119 |
|
|
2025
Q1 | – | Sell |
-249,114
| Closed | -$5.49M | – | 477 |
|
|
2024
Q4 | $5.49M | Buy |
+249,114
| New | +$4.53M | 0.41% | 56 |
|
|
2024
Q3 | – | Sell |
-24,304
| Closed | -$394K | – | 436 |
|
|
2024
Q2 | $394K | Buy |
+24,304
| New | +$374K | 0.04% | 256 |
|
|
2022
Q4 | – | Sell |
-178,831
| Closed | -$1.44M | – | 332 |
|
|
2022
Q3 | $1.44M | Buy |
+178,831
| New | +$1.58M | 0.24% | 106 |
|
|
2022
Q2 | – | Sell |
-15,965
| Closed | -$149K | – | 307 |
|
|
2022
Q1 | $149K | Buy |
+15,965
| New | +$133K | 0.02% | 191 |
|
|
2021
Q4 | – | Sell |
-80,731
| Closed | -$786K | – | 449 |
|
|
2021
Q3 | $786K | Buy |
+80,731
| New | +$756K | 0.07% | 228 |
|
|
2021
Q2 | – | Sell |
-25,059
| Closed | -$289K | – | 584 |
|
|
2021
Q1 | $289K | Buy |
+25,059
| New | +$287K | 0.02% | 415 |
|
|
2020
Q2 | – | Sell |
-91,514
| Closed | -$821K | – | 682 |
|
|
2020
Q1 | $821K | Buy |
+91,514
| New | +$938K | 0.09% | 234 |
|
|
2019
Q4 | – | Sell |
-996,548
| Closed | -$6.86M | – | 768 |
|
|
2019
Q3 | $6.86M | Sell |
996,548
-139,732
| -12% | -$1.07M | 0.37% | 76 |
|
|
2019
Q2 | $10.5M | Buy |
1,136,280
+651,280
| +134% | +$7.85M | 0.41% | 55 |
|
|
2019
Q1 | $7.6M | Buy |
485,000
+388,900
| +405% | +$6.86M | 0.44% | 50 |
|
|
2018
Q4 | $1.48M | Buy |
+96,100
| New | +$1.97M | 0.08% | 234 |
|
|
2018
Q2 | – | Sell |
-810,700
| Closed | -$13.9M | – | 925 |
|
|
2018
Q1 | $13.9M | Buy |
810,700
+656,900
| +427% | +$12.8M | 0.24% | 96 |
|
|
2017
Q4 | $2.91M | Sell |
153,800
-1,843,400
| -92% | -$27.7M | 0.04% | 424 |
|
|
2017
Q3 | $35.1M | Buy |
1,997,200
+1,856,500
| +1,319% | +$41.8M | 0.4% | 54 |
|
|
2017
Q2 | $4.67M | Buy |
+140,700
| New | +$4.36M | 0.07% | 343 |
|
|
2017
Q1 | – | Sell |
-134,900
| Closed | -$4.89M | – | 897 |
|
|
2016
Q4 | $4.89M | Buy |
+134,900
| New | +$5.39M | 0.12% | 261 |
|
|
2016
Q1 | – | Sell |
-48,300
| Closed | -$3.17M | – | 931 |
|
|
2015
Q4 | $3.17M | Sell |
48,300
-118,800
| -71% | -$7.34M | 0.19% | 136 |
|
|
2015
Q3 | $9.43M | Buy |
+167,100
| New | +$10.8M | 0.71% | 23 |
|
|
2015
Q2 | – | Sell |
-105,200
| Closed | -$6.55M | – | 685 |
|
|
2015
Q1 | $6.55M | Buy |
105,200
+81,400
| +342% | +$4.73M | 0.63% | 26 |
|
|
2014
Q4 | $1.37M | Sell |
23,800
-13,700
| -37% | -$763K | 0.21% | 103 |
|
|
2014
Q3 | $2.02M | Buy |
+37,500
| New | +$1.99M | 0.39% | 46 |
|
|
2014
Q1 | – | Sell |
-23,600
| Closed | -$945K | – | 726 |
|
|
2013
Q4 | $945K | Buy |
+23,600
| New | +$929K | 0.09% | 205 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Quantitative Investment Management's TEVA Position: Q2 2026 in Review
Quantitative Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 76,682 shares — an estimated $2.31M sold.
Quantitative Investment Management first reported a position in TEVA in Q4 2013 and held it in 23 quarters. The position peaked at $35.1M in Q3 2017. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Quantitative Investment Management reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Quantitative Investment Management sold 76,682 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.31M.
- Quantitative Investment Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 23 quarters.
- Quantitative Investment Management's Teva Pharmaceuticals position peaked at $35.1M in Q3 2017.
- 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.